Codon-optimized TDP-43 mediates neurodegeneration in a Drosophila model of ALS/FTLD

Codon-optimized TDP-43 mediates neurodegeneration in a Drosophila model of ALS/FTLD

Transactive response DNA binding protein-43 (TDP-43) is known to mediate neurodegeneration associated with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). The exact mechanism by which TDP-43 exerts toxicity in the brains, spinal cord, and lower motor neurons of affe...

Full description

Bibliographic Details
Main Authors:	Tanzeen Yusuff, Ya-Chu Chang, Tzu-Kang Sang, George R. Jackson, Shreyasi Chatterjee
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Genetics
Subjects:	Drosophila neurodegeneration TDP-43 ALS FTLD
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2023.881638/full

Similar Items

The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons
by: Daiyu Honda, et al.
Published: (2014-01-01)

The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
by: Britt A. Berning, et al.
Published: (2019-04-01)

Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies
by: Marta del Campo, et al.
Published: (2021-10-01)

Prion-like Spreading of Disease in TDP-43 Proteinopathies
by: Emma Pongrácová, et al.
Published: (2024-11-01)

Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology
by: Yuan Tian, et al.
Published: (2021-12-01)

Alternative 3′ UTR polyadenylation is disrupted in the rNLS8 mouse model of ALS/FTLD
by: Randall J. Eck, et al.
Published: (2025-01-01)

Progranulin Deficiency Induces Mitochondrial Dysfunction in Frontotemporal Lobar Degeneration with TDP-43 Inclusions
by: Guiomar Rodríguez-Periñán, et al.
Published: (2023-02-01)

TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration
by: Marina Buciuc, et al.
Published: (2022-01-01)

Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family
by: Anne Sieben, et al.
Published: (2018-01-01)

HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP‐43 proteinopathies
by: Cheng‐Chun Wu, et al.
Published: (2020-05-01)

Identification of TCERG1 as a new genetic modulator of TDP-43 production in Drosophila
by: Marine Pons, et al.
Published: (2018-12-01)

Restoring functional TDP-43 oligomers in ALS and laminopathic cellular models through baicalein-induced reconfiguration of TDP-43 aggregates
by: Hsiang-Yu Chang, et al.
Published: (2024-02-01)

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
by: Sarah Pickles, et al.
Published: (2022-07-01)

Insulin-Mediated Changes in Tau Hyperphosphorylation and Autophagy in a Drosophila Model of Tauopathy and Neuroblastoma Cells
by: Shreyasi Chatterjee, et al.
Published: (2019-08-01)

TDP-43 Proteinopathies: A New Player in Neurodegenerative Diseases with Defective Protein Folding
by: Suna Lahut, et al.
Published: (2012-03-01)

TDP-43 Proteinopathies: A New Player in Neurodegenerative Diseases with Defective Protein Folding
by: Suna Lahut, et al.
Published: (2012-03-01)

Regional and hemispheric susceptibility of the temporal lobe to FTLD-TDP type C pathology
by: V. Borghesani, et al.
Published: (2020-01-01)

A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects
by: Simona Langellotti, et al.
Published: (2016-06-01)

Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72
by: Mauricio Budini, et al.
Published: (2017-05-01)

Distinct molecular patterns of TDP-43 pathology in Alzheimer’s disease: relationship with clinical phenotypes
by: Sandra O. Tomé, et al.
Published: (2020-04-01)

Increase in wasteosomes (corpora amylacea) in frontotemporal lobar degeneration with specific detection of tau, TDP-43 and FUS pathology
by: Raquel Alsina, et al.
Published: (2024-06-01)

Heterogeneous Nuclear Ribonucleoprotein E2 (hnRNP E2) Is a Component of TDP-43 Aggregates Specifically in the A and C Pathological Subtypes of Frontotemporal Lobar Degeneration
by: Wejdan Kattuah, et al.
Published: (2019-06-01)

The RNA-Recognition Motifs of TAR DNA-Binding Protein 43 May Play a Role in the Aberrant Self-Assembly of the Protein
by: Elsa Zacco, et al.
Published: (2018-10-01)

Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors
by: Luigi Fiondella, et al.
Published: (2023-04-01)

Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
by: Archana Prasad, et al.
Published: (2019-02-01)

Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid
by: Yanaika S. Hok-A-Hin, et al.
Published: (2022-10-01)

Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
by: Shunsuke Koga, et al.
Published: (2023-07-01)

Parkin beyond Parkinson’s Disease—A Functional Meaning of Parkin Downregulation in TDP-43 Proteinopathies
by: Katarzyna Gaweda-Walerych, et al.
Published: (2021-12-01)

TDP-43 and ER Stress in Neurodegeneration: Friends or Foes?
by: Lorena de Mena, et al.
Published: (2021-10-01)

Mechanisms underlying TDP-43 pathology and neurodegeneration: An updated Mini-Review
by: Benjamin I. Nilaver, et al.
Published: (2023-03-01)

Valosin-containing protein Asp395Gly mutation in a patient with frontotemporal dementia: a case report
by: Ryota Kobayashi, et al.
Published: (2022-11-01)

ALS-linked TDP-43M337V knock-in mice exhibit splicing deregulation without neurodegeneration
by: Seiji Watanabe, et al.
Published: (2020-01-01)

TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
by: Yuting Ren, et al.
Published: (2021-06-01)

Importance of Functional Loss of FUS in FTLD/ALS
by: Shinsuke Ishigaki, et al.
Published: (2018-05-01)

Aberrant TDP‐43 phosphorylation: a key wind gap from TDP‐43 to TDP‐43 proteinopathy
by: Zi‐Qi Huang, et al.
Published: (2021-06-01)

TDP-43 Pathology in Alzheimer’s Disease
by: Axel Meneses, et al.
Published: (2021-12-01)

RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
by: Julie C Necarsulmer, et al.
Published: (2023-10-01)

Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes
by: Shinsuke Ishigaki, et al.
Published: (2017-01-01)

TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Lumi Zhang, et al.
Published: (2020-01-01)

TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43
by: Juan M. Godoy-Corchuelo, et al.
Published: (2024-04-01)